Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Keros Therapeutics, Inc. Common Stock | KROS

Daily Technical Analysis of Keros Therapeutics, Inc. Common Stock

Keros Therapeutics had a nice pop today and is currently up 6.77% -- which is pretty good. Investors have a more positive outlook for the company and future revenue.

It looks like Keros Therapeutics isn't currently at a very decisive point in regards to support/resistance levels. Keros Therapeutics has looked pretty good over the last few months. It has definitely cuaght a bid and had a nice run. Over the last 3 months, shareholders are up 1.12 percent. KROS might find some support at the 58.9 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2024-03-17

Analyst Ratings for Keros Therapeutics By Price Target And Rating

Keros Therapeutics has an overall positive view by the analysts. The current Analysts Sentiment Score is 141.96. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. On 2024-03-01 HC Wainwright reiterated their rating of Buy and added a price target of $100.00. On 2024-02-29 there was confirmation of the previous rating by Wedbush which was Outperform and provided a price target of $86.00. William Blair reiterated a rating of Outperform on 2024-02-21. On 2023-12-08 Wells Fargo & Company initiated their coverage and rated as Overweight and they set their price target at $60.00.Bank of America announced that they are initiating coverage with a rating of Buy on 2023-07-26 and added a price target of $65.00. Piper Sandler announced a lowering of their price target to $110.00 from $120.00 on 2023-05-05.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
KROS141.96180.310104.06-0.45

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-04-19)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
KROS0.000.00

Short interest for Keros Therapeutics

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
KROS6.3%66.42.8381270000

Social Sentiment for Keros Therapeutics

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
KROS

Companies with the highest correlation to Keros Therapeutics

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
EB | Eventbrite, Inc. Class A 0.853.461.70-0.74-37.08-35.10-24.9740-23.12-26.10-10.88-57305.19201.750013.644
RDFN | Redfin Corporation Common0.738.497.25-14.46-35.039.34-21.6239-19.34-14.50-11.48-21022.70-3466.520012.006
INSM | Insmed, Inc.0.67-0.482.86-7.19-13.07-2.9428.83317.289.3544.47-3030.47-14664.07009.8069
RCKT | Rocket Pharmaceuticals, I0.66-0.54-7.92-17.74-24.6721.6426.103812.1832.4236.89-2746.04-17665.95009.12889
SSYS | Stratasys Inc (ISRAEL)0.632.661.93-11.87-25.06-1.13-30.5639-7.00-9.28-5.24-23594.68-1777.49001.74011
PRO | Pros Holdings, Inc.0.630.151.04-6.65-4.584.2318.69355.3010.6321.27-4345.53-554.570011.4181

Top 3 correlating companies

See full charts for all peers

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-